Annals of Family Medicine
NOVEMBER 20, 2024
Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter.
Physician's Weekly
JUNE 19, 2025
Data came from the three influenza seasons from 2012 to 2015. Most patients (71.0%) had received the current season’s RSV vaccine. Melissa Andrew, MD, PhD , and colleagues assessed data from a severe outcomes surveillance network housed within a larger immunization research network. Additionally, 63.8% of the patients were women.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law
JUNE 7, 2021
As an aside, we have found this inconsistency between which accelerated approval therapies are saddled with this sentence to be a paradoxical FDA policy as there is but a single standard for surrogate endpoints to be utilized for purposes of every Accelerated Approval (i.e., be “reasonably likely to predict” ultimate clinical benefit).
FDA Law
AUGUST 21, 2023
Further, FDA has utilized a variety of strategies to call attention to safety issues through Dear Doctor letters or other forms of communication, even if directing changes to labeling is difficult. Liability is precisely why the vaccine market shrunk so significantly in the 1980s, going from 26 manufacturers to 4, after lawsuits claiming $3.5
FDA Law
SEPTEMBER 14, 2021
For drugs approved on or before July 1, 2015, the inflation rebates would be payable beginning 3Q 2023, and for those approved after that date, rebates would be payable beginning with the later of 3Q 2023 or the sixth full calendar quarter after launch. The Part B rebate would exclude vaccines as well.
Expert insights. Personalized for you.
130 
Let's personalize your content